Início › Câncer Endometrial › Pensilvânia

Ensaios clínicos de Câncer Endometrial em Pensilvânia

42 estudos para Câncer Endometrial estão buscando participantes em locais em Pensilvânia.

Cidades em Pensilvânia

Texto oficial do estudo (Inglês)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
UPMC Altoona, Altoona
Lehigh Valley Hospital - Muhlenberg, Bethlehem
e mais 18

RecrutandoFase 2

Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

NRG Oncology, Philadelphia
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Thomas Jefferson University Hospital, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Mulheres · Atualizado em 2 de out. de 2026 · NCT05950464

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
IRMC Cancer Center, Indiana
UPMC Hillman Cancer Center - New Castle, New Castle
e mais 2

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

UPMC Hillman Cancer Center Erie, Erie
UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg
Penn State Milton S Hershey Medical Center, Hershey
e mais 7

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 2 de out. de 2026 · NCT07198074

A Phase 1 Study of the Safety and Tolerability of CTX-10726

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07419841

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia

RecrutandoFase 1

Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

UPMC-Heritage Valley Health System Beaver, Beaver
UPMC Hillman Cancer Center at Butler Health System, Butler
UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
e mais 22

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 28 de set. de 2026 · NCT05112601

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251

DESTINY-PANTUMOUR04

Research Site, Philadelphia

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Philadelphia
Research Site, Pittsburgh

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06218914

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Perelman School of Medicine at the University of Pennsylvania, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT04590326

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Penn State Milton S Hershey Medical Center, Hershey
Paoli Memorial Hospital, Paoli
Thomas Jefferson University, Philadelphia
e mais 2

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

University of Pittsburgh Medical Center, Pittsburgh

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

St. Luke's University Health Network ( Site 6041), Bethlehem
Hospital of the University of Pennsylvania ( Site 5007), Philadelphia
AHN West Penn Hospital ( Site 6006), Pittsburgh

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT06952504

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Lancaster General Health - Ann B. Barshinger Cancer Institute, Lancaster
University of Pennsylvania, Philadelphia

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT05758688

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of Pennsylvania, Philadelphia
WellSpan Medical Oncology & Hematology at York Cancer Center, York

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT05123482

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Philadelphia
Research Site, Pittsburgh

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07216105

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1

Idades 15 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Pittsburgh of UPMC, Pittsburgh

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
UPMC, Pittsburgh

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06774963

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

West Penn Hospital, Pittsburgh

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 21 de ago. de 2026 · NCT05548296

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04104776

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Philadelphia
Normunity Investigational Site, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07182149

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07470853

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Pennsylvania, Perelman School of Medicine, Philadelphia
University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Lehigh Valley Health Network, Allentown

RecrutandoEstudo observacional

Idades 18 e acima · Mulheres · Atualizado em 7 de ago. de 2026 · NCT04291612

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Alliance Cancer Specialist, Doylestown
Allegheny Health Network, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

University of Pennsylvania / Abramson Cancer Center, Philadelphia
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Bethlehem
Research Site, Hershey
Research Site, Lancaster
e mais 5

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 29 de jul. de 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

127, Pittsburgh

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 16 de jul. de 2026 · NCT06906341

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Sidney Kimmel Cancer Center, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT07458347

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

West Penn Allegheny Health, Pittsburgh

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 2 de jun. de 2026 · NCT06730347

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06395519

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Alliance Cancer Specialists, PC, Doylestown
West Penn Hospital, Pittsburgh

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 24 de dez. de 2025 · NCT06463028

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

Abramson Cancer Center at Penn Medicine, Philadelphia
University of Pennsylvania Gynecologic Oncology Department, Philadelphia

RecrutandoFase 1 inicial

Idades 18 e acima · Mulheres · Atualizado em 12 de dez. de 2025 · NCT07278986

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Allegheny Health, Pittsburgh

RecrutandoFase 2

Idades de 18 a 70 · Mulheres · Atualizado em 30 de out. de 2025 · NCT06481592

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.